Profile | GDS5420 / 1555858_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 772.74 | 75 |
GSM1296119 | B_lesional_pre-dose | 808.06 | 76 |
GSM1296076 | C_lesional_pre-dose | 910.93 | 78 |
GSM1296092 | D_lesional_pre-dose | 543.76 | 69 |
GSM1296103 | E_lesional_pre-dose | 266.85 | 57 |
GSM1296078 | F_lesional_pre-dose | 804.39 | 76 |
GSM1296107 | G_lesional_pre-dose | 899.52 | 78 |
GSM1296109 | H_lesional_pre-dose | 846.98 | 77 |
GSM1296080 | I_lesional_pre-dose | 868.43 | 76 |
GSM1296090 | J_lesional_pre-dose | 664.24 | 73 |
GSM1296074 | K_lesional_pre-dose | 593.54 | 71 |
GSM1296111 | L_lesional_pre-dose | 651.09 | 72 |
GSM1296099 | M_lesional_pre-dose | 435.81 | 65 |
GSM1296086 | O_lesional_pre-dose | 686.53 | 73 |
GSM1296117 | P_lesional_pre-dose | 990.13 | 79 |
GSM1296113 | Q_lesional_pre-dose | 810.88 | 76 |
GSM1296096 | R_lesional_pre-dose | 411.82 | 64 |
GSM1296105 | S_lesional_pre-dose | 417.36 | 64 |
GSM1296098 | T_lesional_pre-dose | 491.96 | 67 |
GSM1296101 | U_lesional_pre-dose | 333.07 | 60 |
GSM1296121 | V_lesional_pre-dose | 602.98 | 71 |
GSM1296088 | W_lesional_pre-dose | 525.34 | 68 |
GSM1296082 | X_lesional_pre-dose | 822.71 | 76 |
GSM1296115 | Y_lesional_pre-dose | 669.46 | 73 |
GSM1296084 | Z_lesional_pre-dose | 669.56 | 73 |
GSM1296072 | B_lesional_day8 | 940.76 | 78 |
GSM1296069 | L_lesional_day8 | 737.69 | 74 |
GSM1296071 | P_lesional_day8 | 967.03 | 79 |
GSM1296070 | Y_lesional_day8 | 704.67 | 73 |
GSM1296073 | V_lesional_day8 | 952.66 | 79 |
GSM1296034 | A_lesional_day15 | 545.54 | 68 |
GSM1296041 | G_lesional_day15 | 968.48 | 79 |
GSM1296035 | R_lesional_day15 | 545.38 | 69 |
GSM1296038 | U_lesional_day15 | 319.14 | 60 |
GSM1296047 | B_lesional_day15 | 947.35 | 78 |
GSM1296039 | E_lesional_day15 | 406.44 | 65 |
GSM1296042 | H_lesional_day15 | 1091.75 | 81 |
GSM1296043 | L_lesional_day15 | 963.17 | 79 |
GSM1296037 | M_lesional_day15 | 363.56 | 62 |
GSM1296046 | P_lesional_day15 | 745.28 | 74 |
GSM1296044 | Q_lesional_day15 | 785.31 | 75 |
GSM1296045 | Y_lesional_day15 | 679.37 | 73 |
GSM1296025 | C_lesional_day15 | 1009.56 | 79 |
GSM1296033 | D_lesional_day15 | 618.11 | 71 |
GSM1296027 | I_lesional_day15 | 686.57 | 73 |
GSM1296032 | J_lesional_day15 | 773.29 | 75 |
GSM1296024 | K_lesional_day15 | 928.05 | 78 |
GSM1296031 | W_lesional_day15 | 755.08 | 74 |
GSM1296028 | X_lesional_day15 | 620.39 | 71 |
GSM1296029 | Z_lesional_day15 | 439.26 | 65 |
GSM1296026 | F_lesional_day15 | 677.27 | 73 |
GSM1296030 | O_lesional_day15 | 724.3 | 74 |
GSM1296040 | S_lesional_day15 | 254.6 | 56 |
GSM1296036 | T_lesional_day15 | 727.46 | 74 |
GSM1296048 | V_lesional_day15 | 731.13 | 74 |
GSM1296059 | A_lesional_day43 | 310.89 | 60 |
GSM1296066 | G_lesional_day43 | 857.34 | 77 |
GSM1296060 | R_lesional_day43 | 462.03 | 66 |
GSM1296063 | U_lesional_day43 | 490.93 | 68 |
GSM1296064 | E_lesional_day43 | 306.27 | 60 |
GSM1296067 | H_lesional_day43 | 835.38 | 76 |
GSM1296062 | M_lesional_day43 | 425.91 | 64 |
GSM1296068 | Q_lesional_day43 | 884.81 | 78 |
GSM1296050 | C_lesional_day43 | 1269.25 | 83 |
GSM1296057 | D_lesional_day43 | 518.71 | 68 |
GSM1296052 | I_lesional_day43 | 847.39 | 76 |
GSM1296054 | J_lesional_day43 | 943.65 | 78 |
GSM1296049 | K_lesional_day43 | 959.14 | 78 |
GSM1296055 | W_lesional_day43 | 554.04 | 69 |
GSM1296053 | X_lesional_day43 | 753.68 | 74 |
GSM1296058 | Z_lesional_day43 | 584.92 | 70 |
GSM1296051 | F_lesional_day43 | 605.64 | 71 |
GSM1296056 | O_lesional_day43 | 629.02 | 72 |
GSM1296065 | S_lesional_day43 | 454.2 | 66 |
GSM1296061 | T_lesional_day43 | 857.45 | 76 |
GSM1296095 | A_non-lesional_pre-dose | 310.58 | 60 |
GSM1296120 | B_non-lesional_pre-dose | 895.66 | 78 |
GSM1296077 | C_non-lesional_pre-dose | 828.79 | 76 |
GSM1296093 | D_non-lesional_pre-dose | 518.18 | 68 |
GSM1296104 | E_non-lesional_pre-dose | 279.35 | 58 |
GSM1296079 | F_non-lesional_pre-dose | 1055.5 | 80 |
GSM1296108 | G_non-lesional_pre-dose | 991.75 | 79 |
GSM1296110 | H_non-lesional_pre-dose | 961.9 | 79 |
GSM1296081 | I_non-lesional_pre-dose | 458.4 | 66 |
GSM1296091 | J_non-lesional_pre-dose | 782.19 | 75 |
GSM1296075 | K_non-lesional_pre-dose | 717.24 | 74 |
GSM1296112 | L_non-lesional_pre-dose | 739.82 | 74 |
GSM1296100 | M_non-lesional_pre-dose | 238.5 | 55 |
GSM1296087 | O_non-lesional_pre-dose | 711.29 | 74 |
GSM1296118 | P_non-lesional_pre-dose | 1049.69 | 80 |
GSM1296114 | Q_non-lesional_pre-dose | 686.65 | 73 |
GSM1296097 | R_non-lesional_pre-dose | 457.41 | 66 |
GSM1296106 | S_non-lesional_pre-dose | 482.72 | 67 |
GSM1296102 | U_non-lesional_pre-dose | 539.54 | 68 |
GSM1296122 | V_non-lesional_pre-dose | 941.65 | 78 |
GSM1296089 | W_non-lesional_pre-dose | 643.25 | 72 |
GSM1296083 | X_non-lesional_pre-dose | 361.44 | 62 |
GSM1296116 | Y_non-lesional_pre-dose | 695.79 | 73 |
GSM1296085 | Z_non-lesional_pre-dose | 549.63 | 69 |